Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of August 01, 2025 is 15.16.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 17.49, which is 15.4% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 53.3% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 11.7134 10.4720 17.3300 8.0020 15.1600 56.29%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.314B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $229.344B 16.73
Amgen (AMGN) United States $159.634B 14.30
Gilead Sciences (GILD) United States $140.788B 14.62
Vertex Pharmaceuticals (VRTX) United States $118.674B 0.00
Bristol Myers Squibb (BMY) United States $90.012B 6.57
CSL (CSLLY) Australia $82.413B 0.00
GSK (GSK) United Kingdom $76.680B 8.90
Regeneron Pharmaceuticals (REGN) United States $60.338B 14.41
Alnylam Pharmaceuticals (ALNY) United States $52.390B 0.00
Argenex SE (ARGX) Netherlands $41.237B 72.53
BioNTech SE (BNTX) Germany $25.804B 0.00
Royalty Pharma (RPRX) United States $20.865B 8.81
Insmed (INSM) United States $20.620B 0.00
Biogen (BIIB) United States $19.334B 8.24
Illumina (ILMN) United States $14.985B 22.75
Incyte (INCY) United States $14.761B 18.80
Genmab (GNMSF) Denmark $14.684B 15.02
Genmab (GMAB) Denmark $13.973B 15.67
BioMarin Pharmaceutical (BMRN) United States $11.150B 18.11
QIAGEN (QGEN) Netherlands $11.101B 21.60
Moderna (MRNA) United States $10.676B 0.00
Ascendis Pharma (ASND) Denmark $10.670B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Exelixis (EXEL) United States $10.031B 18.09
Exact Sciences (EXAS) United States $9.009B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.954B 0.00
Bio-Techne Corp (TECH) United States $8.605B 32.10
Roivant Sciences (ROIV) United Kingdom $7.689B 0.00
Halozyme Therapeutics (HALO) United States $7.273B 13.92
Legend Biotech (LEGN) United States $7.130B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.990B 6.86
Revolution Medicines (RVMD) United States $6.823B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Repligen (RGEN) United States $6.681B 72.95
Anbio Biotechnology (NNNN) Germany $6.159B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.618B 0.00
Nuvalent (NUVL) United States $5.584B 0.00
TG Therapeutics (TGTX) United States $5.560B 145.92
Guardant Health (GH) United States $5.165B 0.00
Axsome Therapeutics (AXSM) United States $5.072B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.844B 0.00
ADMA Biologics Inc (ADMA) United States $4.615B 34.52
Abivax SA (ABVX) France $4.566B 0.00
Merus (MRUS) Netherlands $4.538B 0.00
Krystal Biotech (KRYS) United States $4.537B 34.96
Telix Pharmaceuticals (TLX) Australia $4.416B 0.00
Alkermes (ALKS) Ireland $4.383B 12.18
Cytokinetics (CYTK) United States $4.382B 0.00
Avidity Biosciences (RNA) United States $4.329B 0.00
Vaxcyte (PCVX) United States $4.260B 0.00
PTC Therapeutics (PTCT) United States $4.132B 7.19
Zai Lab (ZLAB) China $4.090B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.938B 34.60
Arcellx (ACLX) United States $3.920B 0.00
Akero Therapeutics (AKRO) United States $3.856B 0.00
Zealand Pharma (ZLDPF) Denmark $3.748B 0.00
Viking Therapeutics (VKTX) United States $3.675B 0.00
Metsera (MTSR) United States $3.665B 0.00
Scholar Rock Holding (SRRK) United States $3.452B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.388B 0.00
Protagonist Therapeutics (PTGX) United States $3.336B 71.77
Ascentage Pharma Group - (AAPG) China $3.246B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.012B 0.00
Apellis Pharmaceuticals (APLS) United States $2.884B 0.00
Bavarian Nordic (BVNRY) Denmark $2.879B 15.21
Kymera Therapeutics (KYMR) United States $2.798B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.689B 0.00
Immunovant (IMVT) United States $2.687B 0.00
Alvotech (ALVO) Luxembourg $2.650B 15.16
Mirum Pharmaceuticals (MIRM) United States $2.577B 0.00
Ligand Pharmaceuticals (LGND) United States $2.561B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.340B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.334B 799.50
Recursion Pharmaceuticals (RXRX) United States $2.309B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.200B 0.00
IDEAYA Biosciences (IDYA) United States $2.126B 0.00
Belite Bio (BLTE) United States $2.092B 0.00
ImmunityBio (IBRX) United States $2.092B 0.00
Disc Medicine (IRON) United States $2.042B 0.00
Agios Pharmaceuticals (AGIO) United States $2.027B 0.00
Twist Bioscience (TWST) United States $2.018B 0.00
CG Oncology (CGON) United States $2.005B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.975B 13.13
Denali Therapeutics (DNLI) United States $1.953B 0.00
Amicus Therapeutics (FOLD) United States $1.946B 0.00
Mesoblast (MESO) Australia $1.942B 0.00
Beam Therapeutics (BEAM) United States $1.893B 0.00
Vericel (VCEL) United States $1.794B 296.92
Apogee Therapeutics (APGE) United States $1.738B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.715B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.703B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.657B 0.00
Adaptive Biotechnologies (ADPT) United States $1.569B 0.00
Sarepta Therapeutics (SRPT) United States $1.564B 0.00
Celcuity (CELC) United States $1.553B 0.00
Certara (CERT) United States $1.548B 28.91
Liquidia Technologies (LQDA) United States $1.511B 0.00
Edgewise Therapeutics (EWTX) United States $1.505B 0.00
Biohaven (BHVN) United States $1.502B 0.00
Celldex Therapeutics (CLDX) United States $1.473B 0.00
Jyong Biotech (MENS) Taiwan $1.454B 0.00
Viridian Therapeutics (VRDN) United States $1.421B 0.00
Janux Therapeutics (JANX) United States $1.394B 0.00
Travere Therapeutics (TVTX) United States $1.388B 0.00
ANI Pharmaceuticals (ANIP) United States $1.385B 14.27
WAVE Life Sciences (WVE) Singapore $1.373B 0.00
89BIO (ETNB) United States $1.337B 0.00
Vera Therapeutics (VERA) United States $1.336B 0.00
Dynavax Technologies (DVAX) United States $1.304B 77.57
Cogent Biosciences (COGT) United States $1.298B 0.00
Cidara Therapeutics (CDTX) United States $1.268B 0.00
NovoCure (NVCR) Jersey $1.266B 0.00
AbCellera Biologics (ABCL) Canada $1.265B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Intellia Therapeutics (NTLA) United States $1.190B 0.00
GRAIL (GRAL) United States $1.180B 0.00
MannKind (MNKD) United States $1.140B 23.44
Praxis Precision Medicines (PRAX) United States $1.102B 0.00
Novavax (NVAX) United States $1.063B 2.48
MiMedx (MDXG) United States $1.059B 23.87
Pharvaris (PHVS) Netherlands $1.046B 0.00
Pacira BioSciences (PCRX) United States $1.022B 9.72
Structure Therapeutics (GPCR) United States $1.009B 0.00
Spyre Therapeutics (SYRE) United States $0.980B 0.00
Arcus Biosciences (RCUS) United States $0.970B 0.00
Anavex Life Sciences (AVXL) United States $0.957B 0.00
Immunome (IMNM) United States $0.921B 0.00
Urogen Pharma (URGN) United States $0.896B 0.00
Iovance Biotherapeutics (IOVA) United States $0.895B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Mineralys Therapeutics (MLYS) United States $0.891B 0.00
Sana Biotechnology (SANA) United States $0.882B 0.00
Zymeworks (ZYME) United States $0.876B 0.00
Oric Pharmaceuticals (ORIC) United States $0.862B 0.00
Trevi Therapeutics (TRVI) United States $0.860B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.859B 0.00
LENZ Therapeutics (LENZ) United States $0.855B 0.00
Nurix Therapeutics (NRIX) United States $0.844B 0.00
BGM Group (BGM) China $0.836B 0.00
Upstream Bio (UPB) United States $0.836B 0.00
CorMedix Inc (CRMD) United States $0.789B 52.91
Immatics (IMTX) Germany $0.788B 0.00
Oculis Holding AG (OCS) Switzerland $0.773B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Nuvation Bio (NUVB) United States $0.759B 0.00
UniQure (QURE) Netherlands $0.751B 0.00
Pharming Group (PHAR) Netherlands $0.751B 0.00
Sionna Therapeutics (SION) United States $0.747B 0.00
Geron (GERN) United States $0.745B 0.00
AnaptysBio (ANAB) United States $0.725B 0.00
GH Research (GHRS) Ireland $0.715B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.714B 0.00
Niagen Bioscience (NAGE) United States $0.712B 100.44
Tango Therapeutics (TNGX) United States $0.708B 0.00
Stoke Therapeutics (STOK) United States $0.705B 16.34
Vir Biotechnology (VIR) United States $0.695B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.674B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.668B 0.00
NeoGenomics (NEO) United States $0.667B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.662B 0.00
Dianthus Therapeutics (DNTH) United States $0.662B 0.00
Maze Therapeutics (MAZE) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Zenas BioPharma (ZBIO) United States $0.645B 0.00
ArriVent BioPharma (AVBP) United States $0.638B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.638B 0.00
Arbutus Biopharma (ABUS) United States $0.626B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.625B 0.00
Gyre Therapeutics (GYRE) United States $0.623B 166.25
MeiraGTx Holdings (MGTX) United States $0.615B 0.00
Replimune (REPL) United States $0.591B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.583B 0.00
Keros Therapeutics (KROS) United States $0.582B 0.00
Bicara Therapeutics (BCAX) United States $0.574B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.553B 0.00
Tyra Biosciences (TYRA) United States $0.551B 0.00
Septerna (SEPN) United States $0.544B 0.00
Prime Medicine (PRME) United States $0.543B 0.00
Arvinas (ARVN) United States $0.542B 0.00
Solid Biosciences (SLDB) United States $0.529B 0.00
Opthea (OPT) Australia $0.525B 0.00
Kura Oncology (KURA) United States $0.521B 0.00
Rapport Therapeutics (RAPP) United States $0.516B 0.00
Rezolute (RZLT) United States $0.511B 0.00
Fortrea Holdings (FTRE) United States $0.494B 13.65
Precigen (PGEN) United States $0.493B 0.00
Terns Pharmaceuticals (TERN) United States $0.478B 0.00
Cytek Biosciences (CTKB) United States $0.461B 0.00
MBX Biosciences (MBX) United States $0.460B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
Gossamer Bio (GOSS) United States $0.455B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
Castle Biosciences (CSTL) United States $0.423B 28.73
ATyr Pharma (ATYR) United States $0.418B 0.00
Kamada (KMDA) Israel $0.415B 24.90
REGENXBIO (RGNX) United States $0.411B 0.00
Compass Therapeutics (CMPX) United States $0.408B 0.00
Palvella Therapeutics (PVLA) United States $0.404B 0.00
Erasca (ERAS) United States $0.394B 0.00
Tectonic Therapeutic (TECX) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.386B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Eton Pharmaceuticals (ETON) United States $0.379B 0.00
Northwest Biotherapeutics (NWBO) United States $0.377B 0.00
Astria Therapeutics (ATXS) United States $0.370B 0.00
Absci (ABSI) United States $0.370B 0.00
Fulcrum Therapeutics (FULC) United States $0.369B 0.00
Prothena (PRTA) Ireland $0.367B 0.00
Olema Pharmaceuticals (OLMA) United States $0.365B 0.00
Myriad Genetics (MYGN) United States $0.360B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Kodiak Sciences (KOD) United States $0.351B 0.00
Aura Biosciences (AURA) United States $0.339B 0.00
Verastem (VSTM) United States $0.334B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.334B 0.00
Abeona Therapeutics (ABEO) United States $0.332B 0.00
Cartesian Therapeutics (RNAC) United States $0.320B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.319B 0.00
Candel Therapeutics (CADL) United States $0.315B 0.00
Inhibrx Biosciences (INBX) United States $0.313B 0.19
Neurogene (NGNE) United States $0.311B 0.00
Inventiva S.A (IVA) France $0.308B 0.00
Emergent Biosolutions (EBS) United States $0.306B 0.00
Atea Pharmaceuticals (AVIR) United States $0.297B 0.00
XOMA Royalty (XOMA) United States $0.296B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.295B 59.88
Ocugen (OCGN) United States $0.290B 0.00
Benitec Biopharma (BNTC) United States $0.288B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.279B 0.00
Foghorn Therapeutics (FHTX) United States $0.278B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.278B 0.00
ScPharmaceuticals (SCPH) United States $0.273B 0.00
Annexon (ANNX) United States $0.269B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.267B 0.00
Vor Biopharma (VOR) $0.266B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.264B 0.00
Aardvark Therapeutics (AARD) United States $0.263B 0.00
Lifecore Biomedical (LFCR) United States $0.259B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
Neumora Therapeutics (NMRA) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.251B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.250B 0.00
Monopar Therapeutics (MNPR) United States $0.249B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.247B 0.00
DBV Technologies S.A (DBVT) France $0.247B 0.00
Tvardi Therapeutics (TVRD) United States $0.245B 0.00
Bright Minds Biosciences (DRUG) United States $0.237B 0.00
Allogene Therapeutics (ALLO) United States $0.236B 0.00
Crescent Biopharma (CBIO) United States $0.235B 0.00
Alpha Teknova (TKNO) United States $0.227B 0.00
Alumis (ALMS) United States $0.225B 0.00
Codexis (CDXS) United States $0.223B 0.00
Entrada Therapeutics (TRDA) United States $0.220B 7.16
ProQR Therapeutics (PRQR) Netherlands $0.219B 0.00
Adherex Technologies (FENC) United States $0.217B 0.00
MaxCyte (MXCT) United States $0.217B 0.00
Design Therapeutics (DSGN) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
I-Mab (IMAB) United States $0.214B 0.00
AC Immune (ACIU) Switzerland $0.213B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.205B 0.00
Editas Medicine (EDIT) United States $0.204B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.202B 0.00
Innate Pharma S.A (IPHA) France $0.198B 0.00
EnGene Holdings (ENGN) Canada $0.196B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
CytomX Therapeutics (CTMX) United States $0.189B 4.90
Eupraxia Pharmaceuticals (EPRX) Canada $0.189B 0.00
BioStem Technologies (BSEM) $0.189B 7.66
Ventyx Biosciences (VTYX) United States $0.187B 0.00
Semper Paratus Acquisition (TVGN) United States $0.184B 0.00
Caribou Biosciences (CRBU) United States $0.181B 0.00
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Rapt Therapeutics (RAPT) United States $0.173B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.172B 0.00
SELLAS Life Sciences (SLS) United States $0.166B 0.00
Cellectis S.A (CLLS) France $0.164B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Citius Oncology (CTOR) United States $0.161B 0.00
Elicio Therapeutics (ELTX) United States $0.160B 0.00
Contineum Therapeutics (CTNM) United States $0.154B 0.00
Puma Biotechnology (PBYI) United States $0.152B 3.99
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
C4 Therapeutics (CCCC) United States $0.151B 0.00
Nkarta (NKTX) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Actuate Therapeutics (ACTU) United States $0.149B 0.00
Greenwich LifeSciences (GLSI) United States $0.148B 0.00
BioAge Labs (BIOA) United States $0.148B 0.00
Black Diamond Therapeutics (BDTX) United States $0.147B 43.17
Agenus (AGEN) United States $0.147B 0.00
IO Biotech (IOBT) Denmark $0.146B 0.00
Instil Bio (TIL) United States $0.146B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Alector (ALEC) United States $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Nuvectis Pharma (NVCT) United States $0.142B 0.00
Genelux (GNLX) United States $0.133B 0.00
Compugen (CGEN) Israel $0.132B 0.00
Sangamo Therapeutics (SGMO) United States $0.131B 0.00
Spero Therapeutics (SPRO) United States $0.129B 0.00
23andMe Holding (MEHCQ) United States $0.127B 0.00
BioHarvest Sciences (BHST) Canada $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
Anika Therapeutics (ANIK) United States $0.124B 0.00
Fate Therapeutics (FATE) United States $0.123B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
Immuneering (IMRX) United States $0.121B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.117B 0.00
OKYO Pharma (OKYO) $0.117B 0.00
Connect Biopharma Holdings (CNTB) United States $0.111B 0.00
Tenaya Therapeutics (TNYA) United States $0.109B 0.00
Skye Bioscience (SKYE) United States $0.106B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Zura Bio (ZURA) United States $0.103B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Climb Bio (CLYM) United States $0.098B 0.00
Pliant Therapeutics (PLRX) United States $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Oncolytics Biotech (ONCY) Canada $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.093B 0.00
Scilex Holding (SCLX) United States $0.093B 0.00
TScan Therapeutics (TCRX) United States $0.092B 0.00
Adagene (ADAG) China $0.090B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Immunic (IMUX) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Invivyd (IVVD) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.087B 0.00
XBiotech (XBIT) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.084B 0.00
Elutia (ELUT) United States $0.084B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
Whitehawk Therapeutics (WHWK) United States $0.082B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.079B 0.00
CervoMed (CRVO) United States $0.077B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.076B 0.00
Celularity (CELU) United States $0.075B 0.00
Immix Biopharma (IMMX) United States $0.074B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Cabaletta Bio (CABA) United States $0.073B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Artiva Biotherapeutics (ARTV) United States $0.069B 0.00
Quantum Biopharma (QNTM) Canada $0.069B 0.00
Atara Biotherapeutics (ATRA) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.064B 0.00
Opus Genetics (IRD) United States $0.064B 0.00
Forte Biosciences (FBRX) United States $0.063B 0.00
Applied Therapeutics (APLT) United States $0.062B 0.00
INmune Bio (INMB) United States $0.060B 0.00
Biomea Fusion (BMEA) United States $0.059B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
InflaRx (IFRX) Germany $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Cue Biopharma (CUE) United States $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.052B 0.00
Lantern Pharma (LTRN) United States $0.051B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
PDS Biotechnology (PDSB) United States $0.050B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
KALA BIO (KALA) United States $0.048B 0.00
ABVC BioPharma (ABVC) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Renovaro (RENB) United States $0.044B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
RenovoRx (RNXT) United States $0.044B 0.00
Senti Biosciences (SNTI) United States $0.044B 0.00
Exicure (XCUR) United States $0.044B 0.00
Jasper Therapeutics (JSPR) United States $0.043B 0.00
PepGen (PEPG) United States $0.043B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Cognition Therapeutics (CGTX) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.038B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
Ovid Therapeutics (OVID) United States $0.036B 0.00
Shattuck Labs (STTK) United States $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.033B 0.00
Mersana Therapeutics (MRSN) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
OnKure Therapeutics (OKUR) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.029B 0.00
Clene (CLNN) United States $0.029B 0.00
Generation Bio (GBIO) United States $0.028B 0.00
ALX Oncology Holdings (ALXO) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Cingulate (CING) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Promis Neurosciences (PMN) Canada $0.025B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Q32 Bio (QTTB) United States $0.024B 0.00
Rallybio (RLYB) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
180 Life Sciences (ATNF) United States $0.021B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.020B 0.00
Moleculin Biotech (MBRX) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.019B 0.00
BioAtla (BCAB) United States $0.019B 0.00
Passage Bio (PASG) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Curis (CRIS) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.015B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
MetaVia (MTVA) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
IBio (IBIO) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Synaptogenix (TAOX) United States $0.008B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Apollomics (APLM) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00